MisvikBiology

Misvik works to find better cures for rare cancers

[MisvikBiology @MisvikB]

@DrOpu15 @ShefUni_ClinMed @commschols @Nanobug_Shef Looking good Maruf👍 Hope you have a great meeting!

[MisvikBiology @MisvikB]

Congratulations Ivaska Lab! What a great honor for us to contribute to this elegant piece of science! The cell microarray technologies still got it😃 Interested to develop your custom microarray platform? Contact us for more info! https://t.co/gGPIAvoPED @IvaskaLab @PNASNews

[MisvikBiology @MisvikB]

Target discovery using RNAi screening is still a valid approach. This time a novel DDR target FBXL12 for cancer therapy. Congratulations Sangfelt Lab! https://t.co/p7hEhgdyr3

[MisvikBiology @MisvikB]

Last Call! Calling all early career researchers interested on nanomedicine and looking for a PhD position. Application period to @MelomanesMSCA training network is closing! #PhD https://t.co/2lcPMosQf7

[MisvikBiology @MisvikB]

Huge congratulations to our newest Dr, Dr Patyra🎩🏆 Next three on the line😀 Go team Misvik! @MisvikB

[PrecisionTox @PrecisionTox]

The dream-team working for a better environment gathered in Barcelona!

[PrecisionTox @PrecisionTox]

WEBINAR - 1 June: MEP @JytteGuteland (S&D) & PrecisionTox invite you to discuss "Better Chemical Safety for a Toxic-Free environment: Aiming for 100% REACH Compliance".

>> RSVP to Ryan Hunter: [email protected]

#NAMs #3Rs #EuropeanParliament #chemicals #environment

[Cancer IO @Cancer_IO_]

CancerBio Summer School and Cancer IO present:
​
Special #Sebinar on "Hallmarks of Cancer: New Dimensions" by Professor Douglas Hanahan, the Swiss Institute for Experimental Cancer Research @EPFL_en

Welcome to join the Zoom event on 25 May at 13-14 EEST https://t.co/sbSHfUI2q5✨

[PrecisionTox @PrecisionTox]

Do you want to join a team of scientists working towards precision toxicology? The University of Birmingham is looking for a Data Analyst in Bioinformatics and Biostatistics - deadline: 26th of May

https://t.co/2QJlRwylUw

[MisvikBiology @MisvikB]

Our clical study: Ex vivo determined cancer therapy #EVIDENT is now recruiting! https://t.co/NgvYiOwp84

[MisvikBiology @MisvikB]

During these dark times one needs to find happiness from the small things. Well, today we celebrate our 8th anniversary! What a ride it’s been. Great science, great projects and most importantly great people and customers. Thank you for allowing us to work with you🥂🎉

[MisvikBiology @MisvikB]

Congratulations to Dr Sami Ventelä and colleagues for the great study! https://t.co/bBZ7KA72k5

[MisvikBiology @MisvikB]

Are you interested in the regulation of mesenchymal tumor phenotype in human cancers. Check out our latest work fresh off the press at Molecular Cell. https://t.co/vfnxxC6uzy

[Cancer IO @Cancer_IO_]

The first version of the Cancer IO Ecosystem map is now online! See the map and check the key players in the Finnish IO Ecosystem.

At this stage, the map includes all Cancer IO partners. Would you like to be involved - contact us! https://t.co/1EJgnB6eec @BusinessFinland

[MisvikBiology @MisvikB]

Even some of the most rare cancers can be caused by well known cancer susceptibility genes. Read our study on DNA repair targeting in an extreme rare cutaneous apocrine carcinoma associated with a Finnish founder mutation on PALB2. https://t.co/UiNPKJnPaF #rarecancer

[MisvikBiology @MisvikB]

Interested in tailor made peptidyl diphenyl phosphonate warheads for analysis of proteolytic networks? Check out our latest collaborative study in Nature Chemical Biology: https://t.co/yQAKMu6oJo

[BNN @bionanonet]

Together with the NanoSafety Cluster @nanocommons & @NanoSolveIT offer a #webinar on the use of #linkeddata #resources #Online SPARQL Access to WikiPathways & AOP-Wiki Webinar" on 23rd March, 3:00 - 4:00 p.m. CET!

Register now: https://t.co/53GHJEhudK

https://t.co/eLLSFtAqQw

[MisvikBiology @MisvikB]

Precision Toxicology consortium aims to protect human health from effects of harmful chemicals https://t.co/6PhI0Qm5cx

[MisvikBiology @MisvikB]

Small but mighty! According to the latest H2020 country statistics, Misvik is ranked second among all Finnish life science, pharma and biotech companies in the number of participation to EC funded research and innovation projects! #IndustrialLeadership #H2020 #misvikbiology

[MisvikBiology @MisvikB]

Last week marked the kick-off of our 6th H2020 EU-funded project HARMLESS. The purpose of the project is to provide tools, guidance and decision support to ensure that the next generation nanomaterials will be harmless! #HARMLESS #IndustrialLeadership #SafebyDesign